<DOC>
	<DOCNO>NCT00761982</DOCNO>
	<brief_summary>The aim study determine safety efficacy autologous CD34+ subset bone marrow stem cell infusion middle cerebral artery patient suffer acute middle cerebral artery stroke .</brief_summary>
	<brief_title>Autologous Bone Marrow Stem Cells Middle Cerebral Artery Acute Stroke Treatment .</brief_title>
	<detailed_description>The propose trial involve recruitment total 20 patient . The cell collect ten subject recruit case , via bone marrow sample . The aspirate centrifuge Ficoll density gradient isolate mononuclear cell , resuspend heparinized isotonic saline infusion area stroke intra-arterially use middle cerebral artery . The investigator monitor case control period 6 month post-stem cell infusion . Initially , subject review one month , three month finally 6 month . Assessment adverse event physical examination measurement laboratory parameter . Assessment efficacy physical examination measurement laboratory , CT MRI parameter .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Infarction , Middle Cerebral Artery</mesh_term>
	<criteria>Symptoms sign clinically definite middle cerebral artery acute stroke . Time stroke onset know treatment start day 5 9 onset . DWIMRI reliably show relevant acute ischemic lesion Extracranial duplex/transcranial Doppler must confirm intra/extracranial artery permeability . The stroke severe ( NIH Stroke Scale &gt; = 8 procedure ) . An age range 1880 year old . Patients inclusion age range . Lacunar infarction . Patients cancer . Patients present previous malignant disease last 5 year , except basal cell carcinoma . Hematological cause stroke . Severe comorbidity . Hepatic renal dysfunction . The patient female childbearing potential ( unless certain pregnancy possible ) breast feeding . Patient likely unavailable followup . Patient evidence life threaten infection life threaten illness . Patient already dependent activity daily live present acute stroke .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>